Compounds > 1-hydroxy-3-amino-2-pyrrolidone
Page last updated: 2024-10-21

1-hydroxy-3-amino-2-pyrrolidone and Epileptiform Neuralgia

1-hydroxy-3-amino-2-pyrrolidone has been researched along with Epileptiform Neuralgia in 2 studies

1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kayser, V2
Latrémolière, A1
Hamon, M1
Bourgoin, S1
Christensen, D1
Gautron, M1
Guilbaud, G1

Other Studies

2 other studies available for 1-hydroxy-3-amino-2-pyrrolidone and Epileptiform Neuralgia

ArticleYear
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
    European journal of pain (London, England), 2011, Volume: 15, Issue:5

    Topics: Analgesics, Non-Narcotic; Animals; Cycloserine; Dihydroergotamine; Disease Models, Animal; Drug Syne

2011
Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Pain, 1999, Volume: 83, Issue:3

    Topics: Analgesics, Opioid; Animals; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Male; Mor

1999